1-15 of 15
Giovanni Blandino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P6-10-09: Mutational landscape of breast cancer patients in ROME trial: preliminary results

Andrea Botticelli, Simone Scagnoli, Pierfranco Conte, Chiara Cremolini, Paolo Antonio Ascierto, Federico Cappuzzo, Massimo Aglietta, Federica Mazzuca, Ettore Capoluongo, Giovanni Blandino, Umberto Malapelle, Marianna Nuti, Giulia D’Amati, Bruna Cerbelli, Giancarlo Pruneri, Mauro Biffoni, Giuseppe Giannini, Francesco Cognetti, Giuseppe Curigliano, Paolo Marchetti
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P6-10-09.
https://doi.org/10.1158/1538-7445.SABCS22-P6-10-09
Published: 01 March 2023
View articletitled, Abstract P6-10-09: Mutational landscape of breast cancer patients in ROME trial: preliminary results
Journal Articles

A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer

Michal Shreberk-Shaked, Bareket Dassa, Sanju Sinha, Silvia Di Agostino, Ido Azuri, Saptaparna Mukherjee, Yael Aylon, Giovanni Blandino, Eytan Ruppin, Moshe Oren
Journal: Cancer Research
Cancer Res (2020) 80 (19): 4145–4157.
https://doi.org/10.1158/0008-5472.CAN-20-0125
Published: 02 October 2020
View articletitled, A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer
Open the PDF for A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract CT261: METAMECH -A Master Observational Trial empowering mechanobiology translational research and mechanobased proof of concept trials in breast cancer

Paolo Luraghi, Luca Lazzari, Maria Vittoria Dieci, Serena Bellani, Chiara Soffientini, Rosario Rizzuto, Antonio Rosato, Vincenzo Costanzo, Giorgio Scita, Giannino Del Sal, Massimiliano Pagani, Marco Foiani, Claudio Tripodo, Silvio Bicciato, Giovanni Blandino, Alberto Zambelli, Valter Torri, Matteo Fassan, PierFranco Conte, Silvia Marsoni, Stefano Piccolo
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT261.
https://doi.org/10.1158/1538-7445.AM2020-CT261
Published: 15 August 2020
View articletitled, Abstract CT261: METAMECH -A Master Observational Trial empowering mechanobiology translational research and mechanobased proof of concept trials in breast cancer
Journal Articles

Abstract 768: miR-378a-5p acts as a positive regulator of melanoma progression

Maria Grazia Tupone, Marta Di Martile, Simona D'Aguanno, Elisabetta Valentini, Marianna Desideri, Sara Donzelli, Andrea Sacconi, Daniela Trisciuoglio, Giovanni Blandino, Donatella Del Bufalo
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 768.
https://doi.org/10.1158/1538-7445.AM2019-768
Published: 01 July 2019
View articletitled, Abstract 768: miR-378a-5p acts as a positive regulator of melanoma progression
Journal Articles

Abstract 350: Che-1/aatf-induced transcriptionally active chromatin promotes cell growth in multiple myeloma

Tiziana Bruno, Francesca De Nicola, Frauke Goeman, Matteo Pallocca, Cristina Sorino, Valeria Catena, Gianluca Bossi, Bruno Amadio, Giovanni Cigliana, Enrico Spugnini, Maria Rosaria Ricciardi, Maria Teresa Petrucci, Alfonso Baldi, Mario Cioce, Giancarlo Cortese, Elisabetta Mattei, Roberta Merola, Umberto Gianelli, Francesco Pisani, Svitlana Gumenyuk, Andrea Mengarelli, Katja Hopker, Thomas Benzing, Aristide Floridi, Claudio Passananti, Giovanni Blandino, Simona Iezzi, Maurizio Fanciulli
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 350.
https://doi.org/10.1158/1538-7445.AM2018-350
Published: 01 July 2018
View articletitled, Abstract 350: Che-1/aatf-induced transcriptionally active chromatin promotes cell growth in multiple myeloma
Journal Articles

Abstract 3162: Endothelin-1 receptor/beta-arrestin-1 pathway promotes invadopodia and metastatic process by integration with hMENA in human serous ovarian cancer

Valentina Caprara, Francesca Di Modugno, Lidia Chellini, Piera Tocci, Francesca Spadaro, Andrea Sacconi, Giovanni Blandino, Paola Nisticò, Anna Bagnato, Laura Rosanò
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3162.
https://doi.org/10.1158/1538-7445.AM2018-3162
Published: 01 July 2018
View articletitled, Abstract 3162: Endothelin-1 receptor/beta-arrestin-1 pathway promotes invadopodia and metastatic process by integration with hMENA in human serous ovarian cancer
Journal Articles

Abstract 1197: Endothelin-1 receptor/β-arrestin1 is an actionable node that regulates YAP/TAZ signaling and chemoresistance in high-grade ovarian cancer

Piera Tocci, Roberta Cianfrocca, Laura Rosanò, Rosanna Sestito, Valeriana Di Castro, Giovanni Blandino, Anna Bagnato
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1197.
https://doi.org/10.1158/1538-7445.AM2017-1197
Published: 01 July 2017
View articletitled, Abstract 1197: Endothelin-1 receptor/β-arrestin1 is an actionable node that regulates YAP/TAZ signaling and chemoresistance in high-grade ovarian cancer
Journal Articles

miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1

Roberto Dinami, Cristiana Ercolani, Eleonora Petti, Silvano Piazza, Yari Ciani, Rosanna Sestito, Andrea Sacconi, Francesca Biagioni, Carlos le Sage, Reuven Agami, Roberta Benetti, Marcella Mottolese, Claudio Schneider, Giovanni Blandino, Stefan Schoeftner
Journal: Cancer Research
Cancer Res (2014) 74 (15): 4145–4156.
https://doi.org/10.1158/0008-5472.CAN-13-2038
Published: 31 July 2014
View articletitled, miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1
Open the PDF for miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1 in another window
Includes: Supplementary data
Journal Articles

Abstract 3010: The advent of miRNAs in the molecular taxonomy of breast cancer

Francesca Biagioni, Noa Bossel, Giulia Fontemaggi, Barbara Antoniani, Anna Di Benedetto, Sabrina Strano, Paola Muti, Marcella Mottolese, Eytan Domany, Giovanni Blandino
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3010.
https://doi.org/10.1158/1538-7445.AM10-3010
Published: 15 April 2010
View articletitled, Abstract 3010: The advent of miRNAs in the molecular taxonomy of breast cancer
Journal Articles

Abstract 2983: Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation

Tiziana Bruno, Agata De Santis, Gianluca Bossi, Silvia Di Agostino, Cristina Sorino, Francesca De Nicola, Simona Iezzi, Annapaola Franchitto, Barbara Benassi, Aristide Floridi, Alfonso Bellacosa, Claudio Passananti, Giovanni Blandino, Maurizio Fanciulli
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2983.
https://doi.org/10.1158/1538-7445.AM10-2983
Published: 15 April 2010
View articletitled, Abstract 2983: Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation
Journal Articles

Negative Regulation of β4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression

Giulia Bon, Selene E. Di Carlo, Valentina Folgiero, Paolo Avetrani, Chiara Lazzari, Gabriella D'Orazi, Maria Felice Brizzi, Ada Sacchi, Silvia Soddu, Giovanni Blandino, Marcella Mottolese, Rita Falcioni
Journal: Cancer Research
Cancer Res (2009) 69 (14): 5978–5986.
https://doi.org/10.1158/0008-5472.CAN-09-0244
Published: 15 July 2009
View articletitled, Negative Regulation of β4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression
Open the PDF for Negative Regulation of β4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression in another window
Includes: Supplementary data
Journal Articles

Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53

Sue Haupt, Silvia di Agostino, Inbal Mizrahi, Osnat Alsheich-Bartok, Mathijs Voorhoeve, Alex Damalas, Giovanni Blandino, Ygal Haupt
Journal: Cancer Research
Cancer Res (2009) 69 (11): 4818–4826.
https://doi.org/10.1158/0008-5472.CAN-08-4010
Published: 01 June 2009
View articletitled, Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53
Open the PDF for Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53 in another window
Includes: Supplementary data
Journal Articles

Abstract #1022: Urinary estrogens and prostate cancer: A case-control study and meta-analysis

Maddalena Barba, Li Yang, Holger Schunemann, Francesca Sperati, Sara Grioni, Saverio Stranges, Kim Westerlind, Giovanni Blandino, Michele Gallucci, Rossella Lauria, Luca Malorni, Paola Muti
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1022.
Published: 01 May 2009
View articletitled, Abstract #1022: Urinary estrogens and prostate cancer: A case-control study and meta-analysis
Journal Articles

Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown

Rosa Puca, Lavinia Nardinocchi, Hilah Gal, Gideon Rechavi, Ninette Amariglio, Eytan Domany, Daniel A. Notterman, Marco Scarsella, Carlo Leonetti, Ada Sacchi, Giovanni Blandino, David Givol, Gabriella D'Orazi
Journal: Cancer Research
Cancer Res (2008) 68 (10): 3707–3714.
https://doi.org/10.1158/0008-5472.CAN-07-6776
Published: 15 May 2008
View articletitled, Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown
Open the PDF for Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown in another window
Includes: Supplementary data
Journal Articles

Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells

Lilach Weisz, Alexander Damalas, Michalis Liontos, Panagiotis Karakaidos, Giulia Fontemaggi, Revital Maor-Aloni, Marina Kalis, Massimo Levrero, Sabrina Strano, Vassilis G. Gorgoulis, Varda Rotter, Giovanni Blandino, Moshe Oren
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2396–2401.
https://doi.org/10.1158/0008-5472.CAN-06-2425
Published: 15 March 2007
View articletitled, Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells
Open the PDF for Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells in another window
Includes: Supplementary data